Internal Medicine

Prof. Dr. Nizameddin Koca

Doctor and researcher Bursa Şehir Hastanesi Bursa
Diabetes Mellitus, Type 2COVID-19Liver CirrhosisObesity
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Diabetes Mellitus, Type 2 7 publications
    Source: OpenAlex / PubMed MeSHView publications
  • COVID-19 4 publications
  • Liver Cirrhosis 2 publications
  • Obesity 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyInternal Medicinesaglik.gov.trFrom source
  • Department name at the sourceİç Hastalıkları (Dahiliye)saglik.gov.trFrom source
  • InstitutionBursa Şehir Hastanesisaglik.gov.trFrom source
  • Area of workDiabetes Mellitus, Type 2Extracted from 7 publications · Model version —From source
  • Publications128 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0003-1457-4366ORCIDFrom source
  • Last synchronised5 November 2026 07:49https://bursasehir.saglik.gov.tr/TR-606541/doktorlarimiz.html#nizameddin-kocasaglik.gov.tr

Scientific work

Publications on Diabetes Mellitus, Type 2

128 publications

  1. The role of lipid-derived indices in patients with MASLD in Turkey: a nationwide, multicenter cross-sectional study

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-45869-4 PMID 42002573 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  2. Hepatic fibrosis severity assessed by FIB-4 index is independently associated with reduced kidney function in patients with metabolic dysfunction-associated steatotic liver disease: a nationwide multicenter study from Türkiye

    Hepatology International, 2026

    DOI 10.1007/s12072-026-11139-8 PMID 42584813 Open-access full textSource: OpenAlex

  3. Discordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients with MASLD: Results from the OBREDI-TR Study

    Diagnostics, 2026

    DOI 10.3390/diagnostics16040547 PMID 41750696 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  4. A Novel Approach to Determining Bone Loss Through Serum Uric Acid Levels: A Retrospective Multicenter Cohort Analysis

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15083020 PMID 42074829 Open-access full textSource: OpenAlex

  5. Glycemic Profiles of a Nation: Findings from Türkiye’s World Diabetes Day Screening Study

    Turkish Journal of Internal Medicine, 2026

    DOI 10.46310/tjim.1828705 Open-access full textSource: OpenAlex

  6. Hidden Burden of Hypertension in Türkiye: A Multi-Center DAHUDER World Hypertension Day Study Reveals Gaps in Awareness, Adherence, and Control

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15093535 PMID 42123267 Open-access full textSource: OpenAlex

  7. Uncoupling Systemic Inflammation from Body Mass Index: The Unseen Role of Visceral Adiposity and Metabolic Phenotypes—A Subgroup Analysis of the Nationwide OBREDI-TR Cohort

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15103794 PMID 42194754 Open-access full textSource: OpenAlex

  8. Model-Dependent Cardiovascular Risk Stratification in Obese Populations: Multicenter Study in Türkiye

    International Journal of General Medicine, 2026

    DOI 10.2147/ijgm.s602816 PMID 42339174 Open-access full textSource: OpenAlex

  9. Beyond awareness: analyzing the incomplete integration and barriers to POCUS implementation: a nationwide study

    Internal and Emergency Medicine, 2026

    DOI 10.1007/s11739-026-04475-y PMID 42502150 Open-access full textSource: OpenAlex

  10. Exploratory Analysis of the C-Reactive Protein–Albumin–Lymphocyte Index and Progression-Free Survival in Early-Stage Classical Hodgkin Lymphoma

    Uludağ Üniversitesi Tıp Fakültesi Dergisi, 2026

    DOI 10.32708/uutfd.2006084 Open-access full textSource: ORCID

View all 128 publications